The increasing incidence of keratoconus disorders, are expected to boost the growth of the global keratoconus treatment market at a CAGR of 4.72% during the forecast period of 2020 to 2027 :

Market Research Future (MRFR) has published a cooked research report on the “Global Keratoconus Treatment Market” that contains the information from 2017 to 2027.


The keratoconus treatment market is expected to register a CAGR of 4.72% during the forecast period of 2020 to 2027.


MRFR recognizes the following companies as the


key players in the global keratoconus treatment market—HOYA Vision Care Company (Japan), Menicon Co., Ltd. (Japan), Cooper Companies, Inc. (US), Bausch Health (Canada), SynergEyes (US), Carl Zeiss Meditec AG (Germany), Contamac (UK), SEED Co., Ltd (Japan), Novartis AG (Switzerland), and Johnson & Johnson Services, Inc (US).

Market Highlights


The global keratoconus treatment market is expected to register a CAGR of4.72% during the forecast period and is expected to hit USD 358.55 million by 2027.


Keratoconus is a progressive eye condition in which the cornea, usually round and small, appears cone-like. Keratoconus frequently has to do with light overexposure, constant eye rubbing, improperly fitting contact lenses and chronic eye irritation. Keratoconus care depends on the seriousness of the disease and how easily the condition progresses.


The global keratoconus treatment market is mainly driven by the increasing incidence of keratoconus disorders, increasing ultraviolet and sun exposure and favorable government funding research and prevention programs of ophthalmic disorders. According to the American Journal of Ophthalmology, around 50-200 of every 100,000 people are afflicted with keratoconus. In addition, ultraviolet is regarded as one of the main causes for the development of keratoconus because of its oxidative damage. Thus, a higher prevalence of keratoconus has been identified in Saudi Arabia, Iran, New Zealand, Israel, and some Pacific Islands due to the high ultraviolet exposure.However, lack of awareness and side effects of keratoconus treatment are expected to hamper the growth of the market during the forecast period.


Access full report @ https://www.marketresearchfuture.com/reports/keratoconus-treatment-market-3861


Segment Analysis


The global keratoconus treatment market has been divided based on keratoconus type, treatment type, and end user.


The market, based on keratoconus type, has been segregated into corneal hydrops, forme fruste keratoconus, posterior keratoconus, keratoglobus, pellucid marginal degeneration, and others.


On the basis of treatment type, the market is bifurcated into lenses, surgery, corneal cross-linking, and others. On the basis of lens type, it can further sub-segmented into soft contact lenses, gas permeable contact lenses, scleral and semi-scleral lenses, piggybacking contact lenses, hybrid contact lenses, prosthetic lenses, and others. Based on surgery type, it can be further sub-segmented into corneal transplant, Intacs, and others.


On the basis of end user, the market is bifurcated into eye clinics, hospitals, and others.


Regional Analysis


The global keratoconus treatment market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and Middle East & Africa. The Americas is expected to command the largest market share due to a well-developed healthcare sectorand ongoing technological advancements in the US. According to the American Journal of Ophthalmology, around 50-200 of every 100,000 people are afflicted with keratoconus.Additionally, a high number of cataract surgeries and thegrowing mergers & acquisitions and product launches in this regionare also contribute to market growth. Europe held a substantial share in the global keratoconus treatment market. This can be attributed to the increasing support from the government, the well-establishedmedical industry in the region and the growing cases of keratoconus.Asia-Pacific is estimated to be the fastest-growing region in the global market owing to the high merger and acquisition activities and product approvals in the region.The keratoconus treatment market in Middle East & Africa is expected to witness steady growth during the review period. In the Middle East, the adoption rate of newer diagnostic instruments was high in countries such as South Africa, the UAE, and Saudi Arabia.


Key Findings of the Study



  • The global keratoconus treatment market was valued at USD 55 millionin 2019 and is expected to register a CAGR of 4.72% during the assessment period

  • The Americas accounted for the largest share of the global market due to the well-developed healthcare sector, well-developed medical facilities, and ongoing technological advancements.

  • Based on keratoconus type, the corneal hydrops segment accounted for the largest market share of 26.7% in 2019.

  • Based on treatment type, the corneal cross-linking segment is expected to register the highest CAGR of 5.04% during the forecast period.

  • Based on the end user, the eye clinics segment accounted for the largest market share with a value of USD 208.97 million in 2019


Some of the players operating in the keratoconus treatment market are HOYA Vision Care Company, Bausch Health, Carl Zeiss Meditec AG, and Novartis AG.